Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G03CX01	LIVIAL	B	Tibolone - 2.5mg	2.5mg	Tablet	1,135,547 L.L
N02BF02	LYRICA	B	Pregabalin - 150mg	150mg	Capsule	3,041,116 L.L
C08CA08	LUSOPRESS	B	Nitrendipine - 20mg	20mg	Tablet, scored	757,927 L.L
N02BF02	LYRICA	B	Pregabalin - 150mg	150mg	Capsule	3,041,116 L.L
C08CA13	LERCADIP	B	Lercanidipine HCl - 10mg	10mg	Tablet, film-scored	1,021,320 L.L
C08CA13	LERCADIP	B	Lercanidipine HCl - 20mg	20mg	Tablet, film-scored	1,679,803 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	598,010 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	2,131,334 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	598,010 L.L
S01GX02	LEVOPHTA	B	Levocabastine HCl - 0.5mg/ml	0.05%	Suspension	682,672 L.L
L01XK01	LYNPARZA	B	Olaparib - 100mg	100mg	Tablet, film coated	230,789,350 L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	230,789,350 L.L
A10AE04	LANTUS SOLOSTAR	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	4,992,375 L.L
A10AE04	LANTUS	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	3,327,354 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 4,000UI (40mg)/0.4ml	4,000UI (40mg)/0.4ml	Injectable solution	886,936 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 8000UI (80mg)/0.8ml	8000UI (80mg)/0.8ml	Injectable solution	1,206,771 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 6000UI (60mg)/0.6ml	6000UI (60mg)/0.6ml	Injectable solution	1,085,825 L.L
B01AB05	LOVENOX	BioTech	Enoxaparin sodium - 2,000UI (20mg)/0.2ml	2,000UI (20mg)/0.2ml	Injectable solution	467,657 L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	51,255,093 L.L
C10AA05	LIPODAR	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,323,685 L.L
C10AA05	LIPONORM	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	967,567 L.L
C10AA05	LORVAST	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,114,045 L.L
J05AR01	LAMIVUDINE/ ZIDOVUDINE ARROW	G	Lamivudine - 150mg, Zidovudine - 300mg		Tablet, coated, scored	15,643,319 L.L
N03AX09	LAMOTRIGINE ARROW LAB	G	Lamotrigine - 100mg	100mg	Tablet, dispersible/ chewable	1,050,885 L.L
N03AX09	LAMOTRIGINE BIOGARAN	G	Lamotrigine - 100mg	100mg	Tablet, dispersible	1,233,647 L.L
N05BA06	LORAZEPAM	G	Lorazepam - 1mg	1mg	Tablet, scored	325,082 L.L
N03AX09	LAMOTRIGINE NORMON	G	Lamotrigine - 100mg	100mg	Tablet, dispersible/ chewable	2,284,532 L.L
N05BA06	LORAZEPAM	G	Lorazepam - 2mg	2mg	Tablet, scored	485,063 L.L
N03AX09	LEPIGINE	G	Lamotrigine - 100mg	100mg	Tablet, scored	1,163,768 L.L

...